Annual Cash & Cash Equivalents
$1.84 M
+$1.25 M+210.61%
December 31, 2021
Summary
- As of February 7, 2025, STAB annual cash & cash equivalents is $1.84 million, with the most recent change of +$1.25 million (+210.61%) on December 31, 2021.
- During the last 3 years, STAB annual cash & cash equivalents has risen by +$1.84 million (+115193.75%).
- STAB annual cash & cash equivalents is now at all-time high.
Performance
STAB Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$506.10 K
-$47.70 K-8.61%
September 30, 2022
Summary
- As of February 7, 2025, STAB quarterly cash and cash equivalents is $506.10 thousand, with the most recent change of -$47.70 thousand (-8.61%) on September 30, 2022.
- Over the past year, STAB quarterly cash and cash equivalents has dropped by -$8.71 million (-94.51%).
- STAB quarterly cash and cash equivalents is now -94.51% below its all-time high of $9.22 million, reached on September 30, 2021.
Performance
STAB Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
STAB Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +210.6% | -94.5% |
| 3 y3 years | +10000.0% | - |
| 5 y5 years | +10000.0% | - |
STAB Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | at low | -72.6% | +232.5% |
| 5 y | 5-year | at high | >+9999.0% | -94.5% | +233.2% |
| alltime | all time | at high | >+9999.0% | -94.5% | +233.2% |
Statera Biopharma Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2022 | - | $506.10 K(-8.6%) |
| Jun 2022 | - | $553.80 K(+263.9%) |
| Mar 2022 | - | $152.20 K(-91.7%) |
| Dec 2021 | $1.84 M | $1.84 M(-80.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2021 | - | $9.22 M(+592.9%) |
| Jun 2021 | - | $1.33 M(+775.7%) |
| Mar 2021 | - | $151.90 K(-74.4%) |
| Dec 2020 | $593.90 K(>+9900.0%) | $593.90 K |
| Dec 2019 | $1600.00 | - |
FAQ
- What is Statera Biopharma annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Statera Biopharma?
- What is Statera Biopharma annual cash & cash equivalents year-on-year change?
- What is Statera Biopharma quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Statera Biopharma?
- What is Statera Biopharma quarterly cash and cash equivalents year-on-year change?
What is Statera Biopharma annual cash & cash equivalents?
The current annual cash & cash equivalents of STAB is $1.84 M
What is the all time high annual cash & cash equivalents for Statera Biopharma?
Statera Biopharma all-time high annual cash & cash equivalents is $1.84 M
What is Statera Biopharma annual cash & cash equivalents year-on-year change?
Over the past year, STAB annual cash & cash equivalents has changed by +$1.25 M (+210.61%)
What is Statera Biopharma quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of STAB is $506.10 K
What is the all time high quarterly cash and cash equivalents for Statera Biopharma?
Statera Biopharma all-time high quarterly cash and cash equivalents is $9.22 M
What is Statera Biopharma quarterly cash and cash equivalents year-on-year change?
Over the past year, STAB quarterly cash and cash equivalents has changed by -$8.71 M (-94.51%)